ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

An Immune-modulatory Strategy to Mitigate Hepatic Ischemia/reperfusion Injury in a Murine Model

A. Kobayashi, A. Wanchoo, S. Farhadi, J. Simonovich, S. Duarte, V. Boominathan, S. Shrestha, G. Hudalla, B. G. Keselowsky, A. Zarrinpar

University of Florida, Gainesville, FL

Meeting: 2021 American Transplant Congress

Abstract number: 602

Keywords: Liver

Topic: Basic Science » Ischemia Reperfusion & Organ Rehabilitation

Session Information

Session Name: Ischemia Reperfusion & Organ Rehabilitation

Session Type: Poster Abstract

Session Date & Time: None. Available on demand.

Location: Virtual

*Purpose: Hepatic ischemia/reperfusion injury (IRI) is the leading cause of early graft dysfunction and contributes to the shortage of donor liver grafts. However, despite its obvious clinical importance, there are no effective therapies to prevent or treat this condition. Indoleamine 2,3-dioxygenase (IDO) is an intracellular enzyme that catalyzes the catabolism of the essential amino acid tryptophan to the product kynurenine. It is well known for inducing a powerful immunosuppressive metabolic programming. To date, studies have mostly focused on prolonging graft survival by overexpressing IDO in the transplanted tissue. PEGylation of therapeutic proteins reduces their immunogenicity and extends systemic circulation time. Here, we PEGylate IDO and evaluate efficacy and safety of this IDO delivery strategy to control the local hepatic inflammatory response in a mouse model of warm hepatic IRI

*Methods: We used a well-established mouse model of partial hepatic IRI. Partial hepatic ischemia was produced in the left and median lobes for 90 minutes followed by 6 hours reperfusion. Male 8-12 week old Balb/c mice were separated into 3 cohorts; PEGylated-IDO (PEG-IDO), IDO, and phosphate buffered saline (PBS) intravenously administered 48 hours prior to inducing ischemic injury.

*Results: PEGylated-IDO significantly improved hepatic IRI; plasma levels of aspartate alanine aminotransferase and alanine aminotransferase at 6 hours after reperfusion were significantly lower in the PEG-IDO group, when compared with those in PBS group (P<0.05). Histological analysis showed significantly less congestion, necrosis, and vacuolization in the PEG-IDO group compared with those in PBS groups (P<0.05) as assessed by Suzuki score. It decreased the local infiltration of the inflammatory cells such as T cells, neutrophils, and macrophages, and it reduced the expression of proinflammatory cytokines and chemokines. Furthermore, apoptosis, as measured by the number of TUNEL+ hepatocytes, was also suppressed in PEG-IDO treated mice.

*Conclusions: The results in this study indicate that PEG-IDO preconditioning protects livers from local inflammation and liver damage induced by hepatic IRI. This metabolic immune-modulatory approach may be a new therapeutic strategy against innate immunity-dominated liver tissue damage.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Kobayashi A, Wanchoo A, Farhadi S, Simonovich J, Duarte S, Boominathan V, Shrestha S, Hudalla G, Keselowsky BG, Zarrinpar A. An Immune-modulatory Strategy to Mitigate Hepatic Ischemia/reperfusion Injury in a Murine Model [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/an-immune-modulatory-strategy-to-mitigate-hepatic-ischemia-reperfusion-injury-in-a-murine-model-2/. Accessed May 9, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences